PHARMACIE VANNESTE
Board
1 director, no change since 2023Director (not named in the articles), permanent representative
appointed by deed of 29-11-2023
term without a fixed end
earlier manager, until 29-11-2023
listed in the 2025 annual accounts, filed on 15-06-2026
Permanent representatives 1
Mandates through the years
2 names, the dashed line is todayDirector (not named in the articles)
Director
BoardEarliermandate already running before its first mention
Mandates as a list
-
- Director, appointed by deed of 25-11-2021, until 29-11-2023
- Director (not named in the articles), appointed by deed of 29-11-2023, still in office
-
- Director, until 25-11-2021
Control
Parent
Equity €579,146
Profit €68,983 in 2025 (profit €96,017 in 2024)
Source: accounts 2025
100%
This company
PHARMACIE VANNESTE
Equity €138,853
Profit €91,542 in 2025
Capital
- Contribution
- €6,200
- Source
- 2025 annual accounts
Owners through the years
as the annual accounts name themOwners as a list
-
- 2023 to 2024: 100%
Source: lists of holdings in the owners' accounts
Articles of association
deed of 29-11-2023 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- “Moitié cédant moitié acquéreurs proportionnellement, cessions entre vifs onéreux gratuit volontaires forcées exclusion retrait usufruit…”
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- First Thursday of June at 11:00